Handelsavisen
prelaunch
PT
PTN.CR Food Processing

Protinal CA

$625,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
$14,00
Open
$14,53
Next earnings
2026-08-09
Ex-dividend
TR 1Y
About

Protinal CA operates in the Food Processing industry, manufacturing and distributing food products to consumers and businesses.

Business. Protinal CA (PTN.CR) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of food products. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Beverages
IndustryFood Processing
Generated · model-assisted
Sell-side consensus
BUY3 analysts
3 buy0 hold0 sell
Avg 12m price target54,33

Analyst recommendations

3 analysts · consensus Buy
Buy3
Hold0
Sell0
12-month price target
54,33
Consensus of sell-side coverage.
Upcoming events
  • EarningsFY 2026 earnings (expected)2026-08-09 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
3 analysts · indicative
Ownership
JANUS HENDERSON GROUP PLC
largest disclosed fund holder
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning PTN.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to PTN.CR. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsFY 2026 earnings (expected)2026-08-09 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Protinal CA (PTN.CR) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of food products. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Beverages
    IndustryFood Processing
    AI synthesis
    GENERATED
    — missing data
    Key takeaways
    • Protinal CA's financial position is currently opaque, with all key financial metrics reported as zero.
    • The company's profitability and returns cannot be assessed due to the absence of revenue and income data.
    • There is no available information on Protinal CA's segments or geographic exposure, limiting the understanding of its business diversification.
    • Growth trajectory and future performance are indeterminate without historical or forward-looking data.
    • No immediate liquidity or dilution risks are flagged, but the lack of financial data introduces uncertainty.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $625,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $0.00
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Inflammatory & Autoimmune Therapeutics
    low · business_description · 2026-07-03
    Metabolic Disease Therapeutics
    low · business_description · 2026-07-03
    Ophthalmic Anti-Inflammatory Therapeutics
    low · business_description · 2026-07-03
    Retinal & Glaucoma Therapeutics
    low · business_description · 2026-07-03
    Sexual Dysfunction Therapeutics
    low · business_description · 2026-07-03

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Corporate eventM&A horizon
    M&A probabilityconf 5 %
    Probability
    5 %
    Base rate
    3 %
    Band
    180-day horizon · target 2026-12-26 · 1,8× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-06-29

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$50,00
    Mean$54,33
    Median$53,00
    High$60,00
    Spot$625,00
    −91.3 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    5 %
    Base rate
    3 %
    Band
    Moderate
    180-day horizon · target 2027-01-23 · 1,8× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 7 681 sh9 grants5 insiders
    • Morris ArleneDirector · Stock Option (Right to Buy) → Common StockAcquired 2 400 @ $21,38grant · 2025-12-09
    • SPANA CARLDirector, President and CEO · Stock Option (Right to Buy) → Common StockAcquired 163 @ $362,50grant · 2025-12-09
    • SPANA CARLDirector, President and CEO · Stock Option (Right to Buy) → Common StockAcquired 595 @ $109,50grant · 2025-12-09
    • SPANA CARLDirector, President and CEO · Stock Option (Right to Buy) → Common StockAcquired 568 @ $91,50grant · 2025-12-09
    • WILLS STEPHEN TExecutive VP and CFO/COO · Stock Option (Right to Buy) → Common StockAcquired 142 @ $362,50grant · 2025-12-09
    • WILLS STEPHEN TExecutive VP and CFO/COO · Stock Option (Right to Buy) → Common StockAcquired 495 @ $91,50grant · 2025-12-09
    • PRENDERGAST JOHN K ADirector · Stock Option (Right to Buy) → Common StockAcquired 1 600 @ $21,38grant · 2025-12-09
    • WILLS STEPHEN TExecutive VP and CFO/COO · Stock Option (Right to Buy) → Common StockAcquired 518 @ $109,50grant · 2025-12-09
    • DUNTON ALAN WDirector · Stock Option (Right to Buy) → Common StockAcquired 1 200 @ $21,38grant · 2025-12-09

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    Source documents
    • Protinal CA Market data — financials · 2026-05-29

    Ownership & reference

    Top holders

    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$2M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$0M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M

    Leadership

    • Carl SpanaPresident, Chief Executive Officer, Director

    Insider activity

    Net selling0 buys · 1 sellsnet -$9K4 insiders · last 365d
    • SPANA CARLDirector, President and CEO · Common StockOther 40 @ $21,38$855 · 2025-12-30
    • WILLS STEPHEN TExecutive VP and CFO/COO · Common StockOther 91 @ $21,38$2K · 2025-12-30
    • WILLS STEPHEN TExecutive VP and CFO/COO · Common StockOther 26 @ $21,38$556 · 2025-12-30
    • SPANA CARLDirector, President and CEO · Common StockOther 143 @ $21,38$3K · 2025-12-30
    • SPANA CARLDirector, President and CEO · Common StockOther 138 @ $21,38$3K · 2025-12-30
    • WILLS STEPHEN TExecutive VP and CFO/COO · Common StockOther 95 @ $21,38$2K · 2025-12-30
    • WILLS STEPHEN TExecutive VP and CFO/COO · Common StockSold 565 @ $16,74$9K · 2025-12-24
    • SPANA CARLDirector, President and CEO · Common StockOther 395 · 2025-12-09
    • SPANA CARLDirector, President and CEO · Common StockOther 380 · 2025-12-09
    • WILLS STEPHEN TExecutive VP and CFO/COO · Common StockOther 345 · 2025-12-09
    • SPANA CARLDirector, President and CEO · Common StockOther 110 · 2025-12-09
    • WILLS STEPHEN TExecutive VP and CFO/COO · Common StockOther 95 · 2025-12-09
    • WILLS STEPHEN TExecutive VP and CFO/COO · Common StockOther 330 · 2025-12-09
    • DUNTON ALAN WDirector · Common StockOther 1 000 · 2025-12-09
    • PRENDERGAST JOHN K ADirector · Common StockOther 1 300 · 2025-12-09
    • SPANA CARLDirector, President and CEO · Common StockOther 51 @ $8,00$408 · 2025-11-14
    • WILLS STEPHEN TExecutive VP and CFO/COO · Common StockOther 95 @ $5,50$522 · 2025-11-14
    • WILLS STEPHEN TExecutive VP and CFO/COO · Common StockOther 79 @ $8,00$632 · 2025-11-14
    • WILLS STEPHEN TExecutive VP and CFO/COO · Common StockOther 33 @ $8,00$264 · 2025-11-14
    • WILLS STEPHEN TExecutive VP and CFO/COO · Common StockOther 22 @ $8,00$176 · 2025-11-14
    • SPANA CARLDirector, President and CEO · Common StockOther 142 @ $5,50$781 · 2025-11-14
    • SPANA CARLDirector, President and CEO · Common StockOther 119 @ $8,00$952 · 2025-11-14
    • SPANA CARLDirector, President and CEO · Common StockOther 33 @ $8,00$264 · 2025-11-14

    Short positioning

    187.2Kshares short+2.2% vs prior
    17.78days to cover
    19.0%short of daily vol
    40fails-to-deliver
    as of 2026-06-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    PTN.CRCanonical
    — · USD

    Intel & risk

    PredictorM&A prob5 %Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    • Debt-to-equity (FY 2025-12-31): 0.56xDerived (calculated)
    • Current ratio (FY 2025-12-31): 2.76xDerived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2023-12-31): 52.6%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 316.0%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -39.6%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 279.7%Derived (calculated)
    • Shareholders' equity (annual): USD 11.47MSEC XBRL filing
    • Cash & equivalents (annual): USD 14.48MSEC XBRL filing
    • Total liabilities (annual): USD 6.46MSEC XBRL filing
    • Current assets (annual): USD 17.47MSEC XBRL filing
    • Total assets (annual): USD 17.93MSEC XBRL filing
    • Shares outstanding (annual): 1.76MSEC XBRL filing
    • Current liabilities (annual): USD 6.33MSEC XBRL filing
    • Capex (YoY) (2025-06-30 vs 2024-06-30): -100.0%Derived (calculated)
    • Operating cash flow (YoY) (2025-06-30 vs 2024-06-30): 32.3%Derived (calculated)
    • Net income (YoY) (2025-06-30 vs 2024-06-30): 41.8%Derived (calculated)
    • R&D expense (YoY) (2025-06-30 vs 2024-06-30): -33.5%Derived (calculated)
    • Operating income (YoY) (2025-06-30 vs 2024-06-30): 22.4%Derived (calculated)
    • EPS (diluted) (YoY) (2025-06-30 vs 2024-06-30): 68.2%Derived (calculated)
    • Revenue (YoY) (2025-06-30 vs 2024-06-30): -100.0%Derived (calculated)
    • Capex (annual): USD 0SEC XBRL filing
    • R&D expense (annual): USD 14.9MSEC XBRL filing
    • Revenue (annual): USD 0SEC XBRL filing
    • Operating cash flow (annual): USD -21.31MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-08-09EVENTUpcomingFY 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-28 03:14 UTCHOLDERInstitutional holding changed
    2026-06-28 03:14 UTCHOLDER1 institutional position change flagged
    2026-05-18FILING8-K filing →
    2026-05-13FILING10-Q filing →
    2026-02-17FILING10-Q filing →
    2025-12-30 00:00 UTCINSIDER24 insider transactions — 2025-12 9 derivative
    2025-12-30 00:00 UTCINSIDER24 insider transactions — 2025-12 9 derivative
    2025-12-30 00:00 UTCINSIDER24 insider transactions — 2025-12 9 derivative
    2025-12-30INSIDERSPANA CARL transacted 40 sh — Director, President and CEO ~$1k
    2025-12-30INSIDERWILLS STEPHEN T transacted 91 sh — Executive VP and CFO/COO ~$2k
    2025-12-30INSIDERWILLS STEPHEN T transacted 26 sh — Executive VP and CFO/COO ~$1k
    2025-12-30INSIDERSPANA CARL transacted 143 sh — Director, President and CEO ~$3k
    2025-12-30INSIDERSPANA CARL transacted 138 sh — Director, President and CEO ~$3k
    2025-12-30INSIDERWILLS STEPHEN T transacted 95 sh — Executive VP and CFO/COO ~$2k
    2025-12-24INSIDERWILLS STEPHEN T sold 565 sh — Executive VP and CFO/COO ~$9k
    2025-12-09INSIDERSPANA CARL transacted 395 sh — Director, President and CEO
    2025-12-09INSIDERSPANA CARL transacted 380 sh — Director, President and CEO
    2025-12-09INSIDERWILLS STEPHEN T transacted 345 sh — Executive VP and CFO/COO
    2025-12-09INSIDERSPANA CARL transacted 110 sh — Director, President and CEO
    2025-12-09INSIDERWILLS STEPHEN T transacted 95 sh — Executive VP and CFO/COO
    2025-12-09INSIDERWILLS STEPHEN T transacted 330 sh — Executive VP and CFO/COO
    2025-12-09INSIDERDUNTON ALAN W transacted 1.0k sh — Director
    2025-12-09INSIDERPRENDERGAST JOHN K A transacted 1.3k sh — Director
    2025-12-09INSIDERDUNTON ALAN W acquired 1.2k sh Stock Option (Right to Buy) — Director
    2025-12-09INSIDERWILLS STEPHEN T acquired 142 sh Stock Option (Right to Buy) — Executive VP and CFO/COO
    2025-12-09INSIDERWILLS STEPHEN T acquired 518 sh Stock Option (Right to Buy) — Executive VP and CFO/COO
    2025-12-09INSIDERWILLS STEPHEN T acquired 495 sh Stock Option (Right to Buy) — Executive VP and CFO/COO
    2025-12-09INSIDERMorris Arlene acquired 2.4k sh Stock Option (Right to Buy) — Director
    2025-12-09INSIDERSPANA CARL acquired 163 sh Stock Option (Right to Buy) — Director, President and CEO
    2025-12-09INSIDERSPANA CARL acquired 595 sh Stock Option (Right to Buy) — Director, President and CEO
    2025-12-09INSIDERPRENDERGAST JOHN K A acquired 1.6k sh Stock Option (Right to Buy) — Director
    2025-12-09INSIDERSPANA CARL acquired 568 sh Stock Option (Right to Buy) — Director, President and CEO
    2025-11-14 00:00 UTCINSIDER8 insider transactions — 2025-11
    2025-11-14 00:00 UTCINSIDER8 insider transactions — 2025-11
    2025-11-14 00:00 UTCINSIDER8 insider transactions — 2025-11
    2025-11-14FILINGFORM 10-Q →
    2025-11-14INSIDERSPANA CARL transacted 51 sh — Director, President and CEO ~$0k
    2025-11-14INSIDERWILLS STEPHEN T transacted 95 sh — Executive VP and CFO/COO ~$1k
    Showing the 40 most recent of 56 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage